Jazz Pharmaceuticals
JAZZ
#2078
Rank
โ‚น644.31 B
Marketcap
โ‚น10,658
Share price
0.23%
Change (1 day)
7.97%
Change (1 year)

Revenue for Jazz Pharmaceuticals (JAZZ)

Revenue in 2024 (TTM): โ‚น333.12 Billion

According to Jazz Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is โ‚น345.28 Billion. In 2023 the company made a revenue of โ‚น319.19 Billion an increase over the revenue in the year 2022 that were of โ‚น302.81 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Jazz Pharmaceuticals from 2005 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚น333.12 B4.36%
2023 โ‚น319.19 B5.41%
2022 โ‚น302.81 B31.48%
2021 โ‚น230.30 B33.24%
2020 โ‚น172.85 B12.13%
2019 โ‚น154.15 B16.59%
2018 โ‚น132.21 B27.93%
2017 โ‚น103.35 B2.22%
2016 โ‚น101.11 B14.85%
2015 โ‚น88.03 B18.44%
2014 โ‚น74.33 B37.92%
2013 โ‚น53.89 B67.99%
2012 โ‚น32.08 B122.75%
2011 โ‚น14.40 B84.96%
2010 โ‚น7.78 B30.66%
2009 โ‚น5.96 B83.66%
2008 โ‚น3.24 B26.62%
2007 โ‚น2.56 B29%
2006 โ‚น1.98 B105.89%
2005 โ‚น0.96 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚น173.95 B-49.62%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
โ‚น22.002 T 6,272.24%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น4.318 T 1,150.78%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
โ‚น1.450 T 320.04%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel